Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery
Professor Cornelis Punt, chair of the Dutch Colorectal Cancer Group, discusses the multi discipline approach used by the DCCG in their work and plans for future collaborations with other groups within Europe.
Prof. Punt goes on to describe the exciting new results in their SCRIPT clinical trial, other hot topics emerging from the EMCCC conference and describes the difficulties developing new biomarkers.
Neoadjuvant PD-1 blockade enables organ preservation in early dMMR tumours without surgery
ESMO 2024: Highlights and analysis
Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures
Head and Neck Cancers
Active surveillance for oesophageal cancer shows improved HRQoL compared to standard surgery
OncoAlert round up July 28th to August 3rd, 2023
The parotid gland; an unusual site of colorectal cancer metastasis
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC
Latest treatments in oesophageal cancer